These findings demonstrate that the anti-tumor activity and the inhibition of calcium influx by PCI-24781 are impaired in RGS2-depleted cells, indicating that RGS2 may be a potential biomarker of PCI-24781 in breast cancer cells. The gene discussed is RGS2; the disease is breast carcinoma.